T
Tasia Poinsatte
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
May 8, 2026
PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium
11:06

Joe MooreHOST
Um, before we dig into any of that for you, could you talk to us, um, about what, what is HAF, Healing Advocacy Fund?
T
11:15Tasia PoinsatteGUEST
Um, so Healing Advocacy Fund is a nonprofit that is active across the thr- the three states that have changed their laws to enable a legal psychedelic therapy program, so that's Oregon, Colorado, and New Mexico.
T
11:28Tasia PoinsatteGUEST
And really our goal as an organization, broadly speaking, is to support safe access to psychedelic healing for those who can benefit.
T
11:36Tasia PoinsatteGUEST
And we see the state access models as the primary pathway right now to expand access, especially to people who aren't, you know, psychonauts, who don't have a lot of experience but are starting to learn about the potential mental health or health effects that they could experience working in a structured setting with psychedelics.
T
11:56Tasia PoinsatteGUEST
Um, but, you know, might not feel comfortable or supported to take that stepOtherwise, um, so these licensed models in these three states, Oregon and Colorado are live, and then New Mexico is coming online within the next year or so, um, are the place where we're seeing at scale people being able to access, um, within a licensed framework, um, with, you know, training and accountability for the facilitators, testing of the medicine itself.
T
12:21Tasia PoinsatteGUEST
Um, and our role as an a- organization is really all of the advocacy around that.
12 MINS LATER